- 公司资讯
- finviz | 2022年06月29日 20:00BioLineRx Enters Co-Development Agreement with GenFleet to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC), Advised by MSQ Ventures
- finviz | 2022年06月28日 19:00BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC)
- finviz | 2022年06月16日 19:00BioLineRx Announces Appointment of Commercial Strategy and Operations Veteran Holly W. May as Chief Commercial Officer
- finviz | 2022年05月12日 22:16BLRX: First Quarter 2022 Operational and Financial Results
- finviz | 2022年05月11日 19:00BioLineRx Reports First Quarter 2022 Financial Results and Provides Corporate Update
- finviz | 2022年05月05日 19:00BioLineRx to Report First Quarter 2022 Results on May 11, 2022
- finviz | 2022年03月17日 20:55BLRX: 2021 Results
- finviz | 2022年03月16日 19:00BioLineRx Reports Year-End 2021 Financial Results and Provides Corporate Update
- finviz | 2022年03月10日 19:00BioLineRx to Report 2021 Annual Results on March 16, 2022
- finviz | 2022年03月03日 19:00BioLineRx Announces Additional Positive Results from Pharmacoeconomic Study Comparing Motixafortide + G-CSF to Plerixafor + G-CSF in Stem Cell Mobilization
- finviz | 2022年01月31日 16:20BLRX: Initiating on BioLineRx: Mobilizing the Troops with Motixafortide
- finviz | 2022年01月24日 19:00BioLineRx Announces Completion of Enrollment of Phase 1/2a Study of Innovative Intratumoral Cancer Vaccine, AGI-134, in Unresectable Metastatic Solid Tumors
- finviz | 2022年01月18日 19:00BioLineRx Announces Successful Completion of Pre-NDA Meeting with FDA for Motixafortide for Stem Cell Mobilization in Multiple Myeloma Patients
- finviz | 2021年12月17日 19:00BioLineRx Provides Highlights from Oral Presentation Delivered at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition
- finviz | 2021年12月15日 19:00BioLineRx Announces Formation of Immuno-Oncology Scientific Advisory Board (SAB)
- finviz | 2021年11月18日 19:00BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update
首页
上页
下页